Petra Mariaria

Ms. Petra Mariaria


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 April 2025 in Tropical Medicine and Health
Verified
Journal Article
Open access
PDF file
AAAdewunmi Akingbola
Adewunmi Akingbola
CAChristopher Abiodun Adegbesan
Christopher Abiodun Adegbesan
OAOlajumoke Adewole
Olajumoke Adewole
CICourage Idahor
Courage Idahor
TOTolani Odukoya
Tolani Odukoya
PMPetra Mariaria
Petra Mariaria
Mpox has re-emerged as a significant public health threat, particularly in Africa. This study explores the key drivers behind the recent resurgence, focusing on epidemiological trends, transmission dynamics, and lessons learned from recent outbreaks. The research involved a comprehensive review of recent mpox outbreaks, analyzing factors, such as socio-economic conditions, environmental influences, and genetic evolution. Findings indicate that the resurgence is linked to the cessation of smallpox vaccination, increased human–wildlife interactions, and rapid urbanization in endemic regions. The virus, which was previously confined to rural areas, has now spread to urban populations, and crossed national borders, driven by high population mobility and socio-economic instability. A notable shift in transmission dynamics has been observed, with increased human-to-human transmission, particularly among men who have sex with men (MSM), contributing to more severe and widespread outbreaks. The study highlights the urgent need to strengthen health systems in Africa, particularly in the areas of diagnostics, surveillance, and public health preparedness. Challenges such as inadequate laboratory infrastructure and delayed response mechanisms have exposed vulnerabilities in current public health frameworks. To prevent future outbreaks, targeted strategies must be implemented, including enhanced community engagement, improved access to vaccines and treatments, and timely, accurate reporting of cases. Coordinated global action is essential to prevent mpox from becoming a more persistent and widespread public health threat. This research discusses the importance of proactive measures and international cooperation in addressing the ongoing threat posed by mpox, particularly in regions with limited healthcare resources.

1 January 2025 in Global Health, Epidemiology and Genomics
Verified
Journal Article
Open access
AAAdewunmi Akingbola
Adewunmi Akingbola
AAAbiodun Adegbesan
Abiodun Adegbesan
KAKolade Adegoke
Kolade Adegoke
JCJoel Chuku
Joel Chuku
OOOlajide Ojo
Olajide Ojo
MOMichael Oladunjoye
Michael Oladunjoye
Background: Chandipura virus (CHPV) is an emerging rhabdovirus primarily affecting pediatric populations in India, causing acute encephalitis syndrome (AES) with high mortality rates. First identified in 1965, CHPV has resurfaced in several outbreaks, the most recent being in 2024, with significant public health implications. The virus is transmitted primarily by sandflies, particularly Phlebotomus spp., and has been associated with a rapid progression of symptoms, leading to severe neurological damage and death. Despite advances in diagnostic techniques, no specific antiviral treatment or licensed vaccine currently exists. Main Body of Abstract: This manuscript reviews the latest findings on CHPV, focusing on diagnostic advancements, treatment strategies, and public health responses. Reverse transcription–polymerase chain reaction (RT‐PCR) and enzyme‐linked immunosorbent assay (ELISA) have emerged as vital tools for rapid and accurate diagnosis, enabling the identification of CHPV in clinical and environmental samples. Antiviral therapies, such as ribavirin and favipiravir, have shown promise in vitro and preclinical models, but human trials are lacking. Additionally, the virus’s unique epidemiology, including its reliance on sandfly transmission, complicates control efforts, particularly in resource‐limited settings. The 2024 outbreak, with a case fatality ratio of over 30%, highlights the urgent need for improved surveillance, vector control measures, and public health interventions to curb the spread of CHPV. Conclusion: Despite considerable progress in diagnostics and experimental treatments, significant challenges remain in controlling CHPV outbreaks. The lack of specific antiviral therapies and vaccines continues to hinder effective management. Strengthened vector control strategies, advanced diagnostic infrastructure, and ongoing research into antiviral development are essential for mitigating the impact of CHPV in affected regions. International collaboration and sustained public health efforts will be crucial in preventing future outbreaks and reducing the disease burden.

10 April 2026 in Human Vaccines & Immunotherapeutics
Verified
Journal Article
Open access
AAAdewunmi Akingbola
Adewunmi Akingbola
CICourage Idahor
Courage Idahor
AAAbiodun Adegbesan
Abiodun Adegbesan
TFTosin Fakiyesi
Tosin Fakiyesi
OAOpeyemi Aikulola
Opeyemi Aikulola
PMPetra Mariaria
Petra Mariaria
Epstein–Barr virus has long been suspected of contributing to the development of systemic lupus erythematosus (SLE), yet the mechanisms linking a ubiquitous viral infection to a relatively uncommon...

8 June 2026 in Human Vaccines & Immunotherapeutics
Verified
Journal Article
Open access
AAAdewunmi Akingbola
Adewunmi Akingbola
AAAbiodun Adegbesan
Abiodun Adegbesan
OAOlajumoke Adewole
Olajumoke Adewole
NENwaeze Emmanuel
Nwaeze Emmanuel
OAOpeyemi Joshua Alabi
Opeyemi Joshua Alabi
PMPetra Mariaria
Petra Mariaria
Routine childhood immunization remains an effective public health intervention for reducing childhood morbidity and mortality from vaccine-preventable diseases. This study examined trends in routine childhood vaccination coverage in Nigeria from 1980 to 2023. We conducted a retrospective secondary descriptive analysis using routine childhood vaccination coverage estimates from the Global Burden of Disease Study 2023. Annual national coverage estimates for BCG, DTP3, Polio3, MCV1, and HepB3 vaccines were analyzed from 1980 to 2023. Temporal trends were assessed using line plots and forest plots with associated 95% uncertainty intervals, and the highest and lowest performing years for each vaccine were identified. Coverage for all assessed vaccines was lowest in 1980, followed by gradual expansion during the late 1980s and early 1990s, stagnation between the mid-1990s and early 2000s, and improvement after 2005. Peak coverage occurred between 2019 and 2021 for most vaccines, with BCG reaching the highest in 2021 at 73.6% (95% UI: 64.7–78.3). However, no vaccine achieved the WHO target of 90% national coverage throughout the study period. Although Nigeria has made measurable progress in routine childhood immunization over four decades, coverage remains below optimal levels, highlighting the need for targeted and equitable immunization strategies.

9 September 2025 in JMIR Research Protocols
Verified
Journal Article
Open access
EOElizabeth Oseku
Elizabeth Oseku
PMPetra Mariaria
Petra Mariaria
HSHenry Semakula
Henry Semakula
CKClare Allelua Kahuma
Clare Allelua Kahuma
MBMartin Balaba
Martin Balaba
RPRosalind Parkes-Ratanshi
Rosalind Parkes-Ratanshi
Background: Sexually transmitted infections are a significant public health concern, particularly in sub-Saharan Africa, where their prevalence remains high. Promoting awareness and reducing stigma are essential strategies for addressing this challenge, but those affected often have limited access to accurate and culturally appropriate health information. Therefore, innovative solutions are essential to enhance sexual health literacy and encourage informed health-seeking behaviors. Artificial intelligence (AI)–enabled tools, such as chatbots, have emerged as promising avenues for delivering accurate and accessible health information. However, their potential is constrained by the lack of contextualized datasets, which are crucial for ensuring their effectiveness and relevance to diverse populations. Objective: This study aims to develop an open access, contextualized dataset of question-and-answer pairs on sexual health and sexually transmitted infections to support the development and training of digital and AI-enabled health information tools. Methods: Using a crowdsourcing approach, questions are being collected from participants aged ≥15 years via online platforms, paper-based submissions, and in-person interactions at public events across sub-Saharan Africa. Each question will be anonymized and reviewed by medical professionals who will provide accurate, evidence-based answers. The dataset will then undergo processing, including cleaning and tagging for AI training, ensuring adherence to findability, accessibility, interoperability, and reusability principles. The final dataset will be published as open access. Results: Data collection began on June 12, 2024, and is ongoing. The data collection process was piloted in Kigali, Rwanda, where 132 questions were collected. As of August 2025, the study had collected over 5620 question-and-answer pairs. The collected data are undergoing a simultaneous rigorous data processing phase in collaboration with health workers who provide evidence-based answers to the questions and new questions based on their experience in the clinic. The data cleaning and processing will enhance the utility of the data for AI applications. Conclusions: The final dataset will be published as open access in 2025, contributing to the development of AI-driven health tools and promoting public health literacy. International Registered Report Identifier (IRRID): DERR1-10.2196/70005

31 July 2026 in Human Vaccines & Immunotherapeutics
Verified
Journal Article
Open access
AAAdewunmi Akingbola
Adewunmi Akingbola
AAAbiodun Adegbesan
Abiodun Adegbesan
EBEmmanuella Akpevwe Benson
Emmanuella Akpevwe Benson
MOMmaduabuchi Ozioko
Mmaduabuchi Ozioko
KAKhalil-Uh-Rahman Abdullah
Khalil-Uh-Rahman Abdullah
PMPetra Mariaria
Petra Mariaria
Childhood immunization has been recognized as one of the most successful and cost-effective public health interventions in history.1,2 Since the launch of the Expanded Programme on Immunization by ...